Jane Street Group, LLC Orchard Therapeutics PLC Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.36 - $0.49 $10,688 - $14,548	29,690 Added 64.61%	75,643 $27,000
Q3 2022 Nov 14, 2022	BUY	$0.45 - $0.69 $20,678 - $31,707	45,953 New	45,953 $23,000
Q3 2022 Nov 14, 2022	BUY	$0.45 - $0.69 $20,678 - $31,707	45,953 New	45,953 $23,000
Q1 2022 May 17, 2022	SELL	$0.7 - $1.51 $56,453 - $121,778	-80,648 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$1.16 - $2.23 $78,939 - $151,753	68,051 Added 540.22%	80,648 $106,000
Q3 2021 Nov 16, 2021	BUY	$2.24 - $4.29 $28,217 - $54,041	12,597 New	12,597 $29,000
Q2 2021 Aug 16, 2021	SELL	$4.39 - $7.23 $48,000 - $79,052	-10,934 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$4.39 - $9.08 $1,576 - $3,259	359 Added 3.39%	10,934 $79,000
Q4 2020 Feb 17, 2021	BUY	$3.86 - $5.07 $40,819 - $53,615	10,575 New	10,575 $46,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.